Filing Details
- Accession Number:
- 0000899243-21-048768
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-17 16:17:23
- Reporting Period:
- 2021-12-15
- Accepted Time:
- 2021-12-17 16:17:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1785530 | Werewolf Therapeutics Inc. | HOWL | Pharmaceutical Preparations (2834) | 823523180 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1857795 | Reid Leonard | C/O Werewolf Therapeutics, Inc. 1030 Massachusetts Avenue, Suite 210 Cambridge MA 02138 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-12-15 | 2,865 | $13.39 | 122,292 | No | 4 | S | Indirect | By The Leonard Revocable Living Trust |
| Common Stock | Disposition | 2021-12-15 | 135 | $13.97 | 122,157 | No | 4 | S | Indirect | By The Leonard Revocable Living Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By The Leonard Revocable Living Trust |
| No | 4 | S | Indirect | By The Leonard Revocable Living Trust |
Footnotes
- The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.84 to $13.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) of this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.93 to $13.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) of this Form 4.
Billionaire Hedge Funds
